PGILX
Price
$33.62
Change
+$0.21 (+0.63%)
Updated
May 8 closing price
Net Assets
622.36M
RGEBX
Price
$69.59
Change
+$0.51 (+0.74%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

PGILX vs RGEBX

Header iconPGILX vs RGEBX Comparison
Open Charts PGILX vs RGEBXBanner chart's image
Putnam Focused Equity Y
Price$33.62
Change+$0.21 (+0.63%)
VolumeN/A
Net Assets622.36M
American Funds Growth Fund of Amer R2E
Price$69.59
Change+$0.51 (+0.74%)
VolumeN/A
Net Assets283.8B
PGILX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGILX vs. RGEBX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGILX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 284B vs. PGILX (622M). PGILX pays higher dividends than RGEBX: PGILX (0.33) vs RGEBX (0.00). PGILX was incepted earlier than RGEBX: PGILX (16 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than PGILX (0.86). PGILX is a more actively managed with annual turnover of: 30.00 vs. RGEBX (25.00). PGILX has a lower initial minimum investment than RGEBX: PGILX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 2.88 vs. PGILX (1.16). PGILX return over 5 years is better than : 65.78 vs. RGEBX (40.75).
PGILXRGEBXPGILX / RGEBX
Total Expense Ratio0.861.0979%
Annual Report Gross Expense Ratio0.861.0979%
Fund Existence16 years11 years-
Gain YTD-4.187-2.590162%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets622M284B0%
Annual Yield % from dividends0.330.00-
Returns for 1 year1.162.8840%
Returns for 3 years31.7332.0399%
Returns for 5 years65.7840.75161%
Returns for 10 years98.3354.75180%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDRX4.240.45
+11.87%
GoodRx Holdings
KAVL0.600.03
+4.37%
Kaival Brands Innovations Group
PNR93.531.75
+1.91%
Pentair plc
SUPV14.60N/A
N/A
Grupo Supervielle SA
BDSX0.35-0.08
-17.91%
Biodesix